506
G. Tsolomiti and A. Tsolomitis
H, 4.13; Br, 20.47; N, 10.76. Found: C, 52.13; H, 3.87; Br, 20.51; N, 10.59. IR
(Nujol mull, cm21): 3286, 3163, 3136, 3105, 1642, 1594, 1536, 1487, 1399,
1
and 1071. H NMR (CDCl3/DMSO-d6): 3.91 (s, 2H, –CH2–), 7.29–7.83
(m, 10H, arom.), 9.00 (br m, 3H, –NþH3), 10.50 (s, 1H, –NHCO–).
2-Aminothiazole-4-phenyl-5-acetamide-N-benzyl, hydrobromide (5b):
Yield 67%, mp 105–1068C. Anal. calcd. for C18H18BrN3OS: C, 53.47;
H, 4.49; Br, 19.76; N, 10.39. Found: C, 53.23; H, 4.21; Br, 19.95; N, 10.11.
IR (Nujol mull, cm21): 3365, 3265, 3077, 1642, 1627, 1598, 1585, 1541,
1
1491, 1415, and 1081. H NMR (CDCl3/DMSO-d6): 3.71 (s, 2H, –CH2–),
4.38 (d, J ¼ 6.2 Hz, 2H, –CH2Ph), 7.20–7.72 (m, 10H, arom.), 8.62 (br m,
1H, –NHCO–), 8.96 (br m, 3H, –NþH3).
2-Aminothiazole-4-phenyl-5-acetamide-N,N-diphenyl, hydrobromide (5c):
Yield 88%, mp 233–2348C. Anal. calcd. for C23H20BrN3OS: C, 59.23;
H, 4.32; Br, 17.13; N, 9.01. Found: C, 58.98; H, 4.11; Br, 17.25; N, 8.83.
IR (Nujol mull, cm21): 3272, 3158, 1648, 1631, 1594, 1572, 1491, 1400,
1
and 1074. H NMR (CDCl3/DMSO-d6): 3.71 (s, 2H, –CH2–), 7.05–7.73
(m, 15H, arom.), 9.13 (br m, 3H, –NþH3).
2-Aminothiazole-4-phenyl-5-acetamide-N,N-dibenzyl, hydrobromide (5d):
Yield 96%, mp 177–1788C. Anal. calcd. for C25H24BrN3OS: C, 60.73; H,
4.89; Br, 16.16; N, 8.50. Found: C, 60.48; H, 4.69; Br, 16.34; N, 8.37. IR
(Nujol mull, cm21): 3340, 3239, 3194, 1642, 1620, 1603, 1578, 1495, 1406,
1
and 1075. H NMR (CDCl3/DMSO-d6): 3.89 (s, 2H, –CH2–), 4.48 and
4.67 (two s, 4H, benzylic protons), 6.88–7.53 (m, 15H, arom.), 9.14 (br m,
3H, –NþH3).
REFERENCES
1. Hargrave, K. D.; Hess, F. K.; Oliver, J. T. N-(4-Substituted-thiazolyl)-oxamic acid
derivatives, new series of potent, orally active antiallergy agents. J. Med. Chem.
1983, 26, 1158–1163.
2. Kane, J. L.; Hirth, B. H.; Liang, B.; Gourlie, B. B.; Nahill, S.; Barsomian, G. Ureas
of 5-aminopyrazole and 2-aminothiazole inhibit growth of gram-positive bacteria.
Bioorg. Med. Chem. Lett. 2003, 13, 4463–4466.
¨
3. Bell, F. W.; Cantrell, A. S.; Hogberg, M.; Jaskunas, S. R.; Johansson, N. G.;
Jordan, C. L.; Kinnick, M. D.; Lind, P.; Morin, J. M., Jr.; Noreen, R. Phenethylthia-
´
zolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase
inhibitors. 1. Synthesis and basic structure –activity relationship studies of
PETT analogs. J. Med. Chem. 1995, 38, 4929–4936.
4. Wiley, R. H. The preparation of thiazoles. In Organic Reactions; Wiley:
New York, 1951; VI, pp. 367–409.
5. Griffin, T. S.; Woods, T. S.; Klayman, D. L. Thioureas in the synthesis of hetero-
cycles. Adv. Heterocycl. Chem. 1975, 18, 99–158.
6. Metwally, M. A.; Abdel-Latif, E.; Amer, F. A.; Kaupp, G. Versatile 2-amino-4-sub-
stituted-1,3-thiazoles: Synthesis and reactions. J. Sulfur Chem. 2004, 25, 63–85.